Biosimilar uptake in the United States lags behind Europe possibly causing the American health care consumer. A report published by the think-tank Pacific Research Institute this past summer implies a low uptake of biosimilars with significant economic consequences...
Costing $409,000 per year in the U.S. by 2010 and by 2015, it was the fifth most expensive medication in the U.S
United States House Speaker Nancy Pelosi is leading the charge for the U.S. federal government via Medicare to negotiate drug prices for high cost drugs in Medicare and the marketplace under a plan that the lawmakers hope would rationalize drug prices. The plan would...
Analysts have put the cost at $4,200 a year
Georgia Institute of Technology Study: Patients Resort to Crowd Funding to Pay for Advanced CAR T-Cell Therapies
An Average Campaign Targets $61,622
Making a Profit on the Price of Wellbeing
Statistics From Over 1000 Participants
Insulin Lispro $137.35 per vial; Novolog $144.68 per vial; Sanofi $99 per month
Novolog—$144.68 per vial ; Insulin Lispro—$137.35 per vial
NHS Has Cut Its Drug Spend by 29%